Factors that determine the treatment for local and regional prostate cancer

被引:85
作者
Desch, CE
Penberthy, L
Newschaffer, CJ
Hillner, BE
Whittemore, M
McClish, D
Smith, TJ
Retchin, SM
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT INTERNAL MED,RICHMOND,VA 23298
[2] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT BIOSTAT,RICHMOND,VA 23298
[3] ST LOUIS UNIV,SCH PUBL HLTH,ST LOUIS,MO 63103
[4] CTR HLTH AFFAIRS,PROJECT HOPE,CHEVY CHASE,MD
关键词
prostate cancer; practice variation; rural; socioeconomic factors; linked database; treatment;
D O I
10.1097/00005650-199602000-00007
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This article assesses the significance of comorbid and nonclinical factors in type of treatment received by elderly male patients with local-regional stage prostate cancer. Multivariate analysis of data from the Virginia Cancer Registry was linked to Medicare claim files, the Area Resource File, and 1990 Census Data. The type of initial treatment received was studied in 3117 men with local-regional staged prostate cancer diagnosed from 1985 to 1989. The frequency of surgical and radiation therapy for prostate cancer rose between 1985 and 1989 (12.5% to 18.5% for surgery, P < 0.001; 25% to 32% for radiation, P < 0.001). Age was the most important predictor of therapeutic choice; no therapy was given to 26% of men 65 to 69 years old versus 63% of men 85 years or older P < 0.001). Race, residence (rural versus urban), and comorbidity were also strong factors in predicting initial therapy. Using logistic regression, three treatment alternatives were evaluated. Age (odds ratio [OR] .51; 99% confidence interval [CI] = .43, .60), comorbidity (OR .72; 99% CI .63, .82), income (OR 1.14; 99% CT 1.01, 1.28), residence (OR .65; 99% CI .48, .87), diagnosis year (OR 1.15; 99% CI 1.07, 1.23) all were associated independently with treatment versus no treatment. For surgery versus radiation, age (OR .40; 99% CI .27, .57), race (OR 2.92; 99% CI 1.65, 5.15) and education (OR 1.75; 99% CI 1.31, 2.34) were significant factors. For hormonal/orchiectomy versus surgery/radiation, age (OR 5.19; 99% CI 3.84, 7.01), comorbidity (OR 1.28; 99% CI 1.03, 1.58), distance to radiation oncologist (OR .89; 99% CI .80, .99), and diagnosis year (OR .89; 99% CI .79, 1.00) were significant. The number of men receiving surgical and radiation treatments for prostate cancer increased between 1985 and 1989. During that period, age consistently played a significant role in all therapeutic decisions. Other factors, such as comorbidity, race, socioeconomic status, and distance, also were important considerations, depending on the treatment alternative.
引用
收藏
页码:152 / 162
页数:11
相关论文
共 25 条
  • [1] BENNETT CL, 1991, CANCER, V67, P2633, DOI 10.1002/1097-0142(19910515)67:10<2633::AID-CNCR2820671039>3.0.CO
  • [2] 2-9
  • [3] RESULTS OF CONSERVATIVE MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER
    CHODAK, GW
    THISTED, RA
    GERBER, GS
    JOHANSSON, JE
    ADOLFSSON, J
    JONES, GW
    CHISHOLM, GD
    MOSKOVITZ, B
    LIVNE, PM
    WARNER, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (04) : 242 - 248
  • [4] CARE OF PATIENTS WITH COLORECTAL-CANCER - A COMPARISON OF A HEALTH MAINTENANCE ORGANIZATION AND FEE-FOR-SERVICE PRACTICES
    FRANCIS, AM
    POLISSAR, L
    LORENZ, AB
    [J]. MEDICAL CARE, 1984, 22 (05) : 418 - 429
  • [5] RACIAL AND COMMUNITY FACTORS INFLUENCING CORONARY-ARTERY BYPASS GRAFT-SURGERY RATES FOR ALL 1986 MEDICARE PATIENTS
    GOLDBERG, KC
    HARTZ, AJ
    JACOBSEN, SJ
    KRAKAUER, H
    RIMM, AA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (11): : 1473 - 1477
  • [6] SOCIAL AND ECONOMIC-FACTORS IN THE CHOICE OF LUNG-CANCER TREATMENT - A POPULATION-BASED STUDY IN 2 RURAL STATES
    GREENBERG, ER
    CHUTE, CG
    STUKEL, T
    BARON, JA
    FREEMAN, DH
    YATES, J
    KORSON, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (10) : 612 - 617
  • [8] HOSPITAL VARIABLES ASSOCIATED WITH QUALITY OF CARE FOR BREAST-CANCER PATIENTS
    HAND, R
    SENER, S
    IMPERATO, J
    CHMIEL, JS
    SYLVESTER, J
    FREMGEN, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (24): : 3429 - 3432
  • [9] HANKS GE, 1988, CANCER, V61, P2153, DOI 10.1002/1097-0142(19880601)61:11<2153::AID-CNCR2820611104>3.0.CO
  • [10] 2-0